Report: Attune total knee seeing “unusually high” rate of early failure

By

Report: DePuy’s Attune knee seeing “unusually high” rate of early failure (MassDevice)
Johnson & Johnson subsidiary DePuy Synthes’ Attune total knee arthroplasty system is experiencing an “unusually high” rate of early failure related to its tibial components, according to a new study
The study, recently published in the Journal of Knee Surgery, explored a number of FDA reports to its Manufacturer and User Facility Device Experience database related to the Attune knee. A search of the MAUDE system results in a total of 232 reports related to the Attune TKA.
In the study, researchers said ...

Get access to full posts newsletters, trends, and market reports for only subscribe for $1/day.
Hit the SUBSCRIBE button at the top of the homepage.